|
1. Biologie
|
|
|
|
3.1 Tabac
|
|
|
|
3.1.1 Tabac - e-cigs
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
|
|
3.8 Prévention - Alimentation
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
Detecting early signs of cancer in the blood [NIH]
|
|
|
|
|
|
These
findings suggest that circulating tumor DNA might be used to help
detect early cancers and guide the care of cancer patients. More studies
are needed in a larger number of people to validate whether this
approach will be helpful in the clinic.
|
|
|
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
Five Prime cuts loose from InhibRx immuno-oncology deal [FierceBiotech]
|
|
|
|
|
|
Five
Prime paid $10 million upfront in July 2015 for the rights to the
GITRs, proteins expressed by the body's T cells that it hoped would help
stimulate an immune system attack on cancerous cells. Another $450
million plus—in cash or Five Prime stock—was dependent on progress with
the program.
|
|
|
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
|
Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing [FiercePharma]
|
|
|
|
|
|
Mitchell’s
estimate that taxpayers funded $200 million worth of CAR-T research is
based on a keyword search on the National Institutes of Health (NIH)
website. Novartis’ academic partner, the University of Pennsylvania, got
about $17 million of that. The rest went to the National Cancer
Institute and more than 60 academic institutions and biotech companies.
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
For Gilead Kite is no Pharmasset [EP Vantage]
|
|
|
|
|
|
And
while Gilead’s move clearly is not cheap – Kite has run up an
accumulated deficit of under $500m since inception – cell therapy has
simply become too important an area for the group not to be in.
|
|
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
|
|
5.6 ESMO
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.10 Politiques
|
|
|
|
6.11 Patients
|
|
|
|
6.5 Médecines alternatives
|
|
|
|
6.6 Publications
|
|
|
|